Fintel reports that on October 27, 2026, William Blair downgraded their outlook for Moderna (BIT:1MRNA) from Outperform to Market Perform. This rating action follows a prior move by William Blair on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results